These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1432919)
1. The how and why of the ADA's evaluation program for dental therapeutic products. Whall CW J Public Health Dent; 1992; 52(6):338-42. PubMed ID: 1432919 [TBL] [Abstract][Full Text] [Related]
2. Voluntary programs: ADA Seal program and international implications. Meyer DM Ann Periodontol; 1997 Mar; 2(1):31-41. PubMed ID: 9151541 [TBL] [Abstract][Full Text] [Related]
3. A researcher's view. Horowitz HS J Public Health Dent; 1992; 52(6):383-6. PubMed ID: 1432932 [TBL] [Abstract][Full Text] [Related]
4. ADA dental product evaluation: case history. Barnett ML J Public Health Dent; 1992; 52(6):343-5. PubMed ID: 1432920 [TBL] [Abstract][Full Text] [Related]
5. Regulation of oral chemotherapeutic products in the United States. Trummel CL J Dent Res; 1994 Mar; 73(3):704-8. PubMed ID: 8163741 [TBL] [Abstract][Full Text] [Related]
6. The how and why of the ADA's evaluation of dental materials, instruments, and equipment. Fan PL J Public Health Dent; 1992; 52(6):369-70. PubMed ID: 1432926 [No Abstract] [Full Text] [Related]
7. Interactions as seen by an industry representative among the FDA, the ADA, and industry in preparing a restorative material for market. Dougherty EW J Public Health Dent; 1992; 52(6):371-2. PubMed ID: 1432927 [TBL] [Abstract][Full Text] [Related]
8. Lists of products evaluated by the Council on Dental Materials and Devices and the Council on Dental Therapeutics. J Am Dent Assoc; 1975 Jan; 90(1):267-76. PubMed ID: 1053638 [No Abstract] [Full Text] [Related]
9. Legal implications of using drugs and devices in the dental office. Wakeen LM J Public Health Dent; 1992; 52(6):403-8. PubMed ID: 1432938 [TBL] [Abstract][Full Text] [Related]
10. FDA and ADA evaluation of dental products--implications for dentists and their patients: a view from the practitioner. Ousborne AL J Public Health Dent; 1992; 52(6):391-3. PubMed ID: 1432934 [TBL] [Abstract][Full Text] [Related]
11. How the FDA and the ADA affect development of prescription drugs for oral care. Cooley WE J Public Health Dent; 1992; 52(6):350-2. PubMed ID: 1432922 [TBL] [Abstract][Full Text] [Related]
12. The Food and Drug Administration's requirements for approval of new dental drugs. Gilkes CC Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180 [No Abstract] [Full Text] [Related]
13. Lists of products evaluated by the Council on Dental Materials and Devices and the Council on Dental Therapeutics. J Am Dent Assoc; 1976 Jan; 92(1):254-64. PubMed ID: 1060688 [No Abstract] [Full Text] [Related]
14. Ethical perspectives on the FDA and ADA evaluation of dental products. Veatch RM J Public Health Dent; 1992; 52(6):387-90. PubMed ID: 1432933 [TBL] [Abstract][Full Text] [Related]
15. Accepted dental products. Council on Dental Materials, Instruments, and Equipment. Council on Dental Therapeutics. J Am Dent Assoc; 1988 Feb; 116(2):249-70. PubMed ID: 3422676 [No Abstract] [Full Text] [Related]
16. What do consumers want? Apple W J Public Health Dent; 1992; 52(6):379-82. PubMed ID: 1432931 [TBL] [Abstract][Full Text] [Related]